According to the Shenwan industry, there are a total of 430 A-share listed pharmaceutical and biological companies
Financing in the pharmaceutical industry is frequent, focusing on cell therapy, ADC, genetic testing and other fields
Time of Update: 2022-04-26
AAV gene therapy new drug research and development company Jinweike recently completed a Pre-A round of financing of tens of millions of yuan .
The United States will officially implement the rapid testing plan for the new crown, 3 domestic pharmaceutical companies are expected to seize the opportunity
Time of Update: 2022-02-23
According to the latest report from CNBC, the monthly demand for the rapid detection reagents (antigen reagents) sent by the US government to the public for free may reach 2.
Under the implementation of the new version of the Pharmacopoeia, microbiological testing equipment in the subdivision of pharmaceutical equipment is promising
Time of Update: 2021-12-29
The 2021 semi-annual report of Tailin Biology shows that the company's main business is the research and development, manufacturing and sales of pharmaceutical equipment such as microbial detection and control technology system products and organic matter analysis instruments .
was announced, containing 9 types of pharmaceutical excipients and 2 general testing methods for pharmaceutical packaging materials
Time of Update: 2021-12-24
> Drafting of Guidelines for Biological Evaluation and Test Selection of Pharmaceutical Packaging Materials
The team of Professor Chongjiang Cao of China Pharmaceutical University constructed
Time of Update: 2021-12-01
Processing Technology has made progress in the multi-functional preservation of harvested vegetables. The research results were published in the authoritative journal Chemical Engineering Journal (Top Journal of the Chinese Academy of Sciences
A big test of Huiyu Pharmaceuticals: It was questioned all the way to officially land on the Sci-tech Innovation Board and enter the capital market
Time of Update: 2021-11-16
As the only generic drug manufacturer that passed the consistency evaluation at that time, Huiyu Pharmaceutical won the bid with a 65% price reduction to seize the market .
Tengshengbo Pharmaceutical submitted an emergency use authorization application for the new crown
Time of Update: 2021-10-22
Currently, the new crown neutralizing antibody BRII-196/BRII-198 "cocktail" therapy is undergoing phase 3 clinical trials in multiple centers around the world .
With the high-quality development of the pharmaceutical industry, the development of testing equipment will usher in great opportunities
Time of Update: 2021-10-07
a new generation of electronic peeling tester in strict accordance with the requirements of the 180-degree peel strength method in the new version of the new pharmacopoeia "0952 Adhesion Test Method". According to reports
Keji Pharmaceutical's CT041 CAR-T treatment of digestive system tumors and advanced gastric cancer efficacy data is eye-catching
Time of Update: 2021-10-01
Solid tumor CAR-T debuts with ESMO clinical treatment data for advanced gastric cancerThe study presented in the 2021 ESMO oral report is a clinical trial initiated by a multi-center, open-label Phase I investigator in China.
Baiyunshan Pharmaceutical Amlodipine Besylate Tablets have passed the quality and efficacy consistency evaluation of generic drugs
Time of Update: 2021-07-31
As of the announcement date, Baiyunshan Pharmaceutical General Factory has invested approximately RMB 4,378,800 in research and development expenses (unaudited) for the consistency evaluation of the drug .
Xianju Pharmaceutical intends to establish joint ventures with Tsinghua University and other companies to lay out the field of diagnostic testing
Time of Update: 2021-07-24
" with Tsinghua University and Quanxinjili (Ningbo) Biotechnology Partnership (Limited Partnership) .
50% of the registered capital; Quanxinjili (Ningbo) Biotechnology Partnership (Limited Partnership) invested 1.
Hongri Pharmaceutical: Fasudil Hydrochloride Injection passed the quality and efficacy consistency evaluation of generic drugs...
Time of Update: 2021-05-23
drugs.
>
It is understood that fasudil hydrochloride injection and developed by Asahi Kasei and Nagoya University, respectively, in 1995 and launched in Japan in 2001 and listed
Hongri Pharmaceutical: Fasudil Hydrochloride Injection Passed the Quality and Efficacy Consistency Evaluation of Generic Drugs
Time of Update: 2021-05-21
In 2004, Asahi Kasei expanded fasudil hydrochloride to treat cerebral thrombosis in Japan for the treatment of acute cerebral thrombosis (within 48 hours after onset).
Baiyunshan Pharmaceutical Amlodipine Besylate Tablets have passed the quality and efficacy consistency evaluation of generic drugs
Time of Update: 2021-03-22
As of the announcement date, Baiyunshan Pharmaceutical General Factory has invested approximately RMB 4,378,800 in research and development expenses (unaudited) for the consistency evaluation of the drug.
6 provinces and regions set up a new free trade test zone, the development of the pharmaceutical industry focus!
Time of Update: 2021-03-04
to the State Council for the record, by the Ministry of Commerce, the Ministry of Natural Resources responsible for the release. Shandong of functions. Jinan District focuses on the development of artificial
The EU and Japan will strengthen cooperation in the testing of pharmaceutical manufacturers
Time of Update: 2021-02-22
The European Union (EU) and Japan have agreed to expand the range of mutually approved medicines to check production sites.
